S4-E13.4 - INCBCN 2023: Not Your Average Conference
Send us Fan Mail Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and...
26 Mar 202311min
S4-E13.3 - Discussing the Day 2 Program of INCBCN in Barcelona
Send us Fan Mail Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and...
25 Mar 202310min
S4-E13.2 - Linking NAFLD and NASH to Cancer and Educating on Fatty Liver Screening
Send us Fan Mail Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and...
25 Mar 202310min
S4-E13.1 - Feedback from the Inaugural INCBCN and Setting the Stage for the 2023 Workshop
Send us Fan Mail Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and...
25 Mar 20239min
S4-E13 - Previewing the 2023 Innovations in NAFLD Care Workshop
Send us Fan Mail Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and...
23 Mar 202344min
S4-E12.6 - From the Vault: Building a Disease Model for NASH Prevalence: Key Challenges
Send us Fan Mail This conversation From the Vault starts with Chris Estes describing the processes he and his colleagues at the Center for Disease Analysis Foundation have used to build a disease mode...
19 Mar 202313min
S4-E12.5 - ICER Draft Report: Different Stakeholder Impacts
Send us Fan Mail Last week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH...
19 Mar 202311min
S4-E12.4 - Biopsy, Biomarkers and Assessing the Value and Pricing of New Medications
Send us Fan Mail Last week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH...
19 Mar 202313min
